SHANGHAI — Shanghai Hanle Biotechnology Co., Ltd. has announced a significant milestone in its corporate development, reinforcing its status as a key innovator in the chemical and biotechnology sectors. Since its establishment in 2012, the company has evolved from a local entity into a global exporter, currently achieving an annual export volume of $30 million USD.
Bridging Science and Industry
The company’s success is attributed to its unique business model that seamlessly integrates research and development with commercial application. By cultivating deep strategic partnerships with leading chemical research institutes and food colleges, Shanghai Hanle Biotechnology has created a robust pipeline for innovation.
Unlike traditional trading firms, Shanghai Hanle Biotechnology operates as a cohesive technology unit. The integration of sales and service with R&D ensures that customer feedback is directly fed back into the development process. This customer-centric approach has resulted in the successful launch of multiple new products, all of which have received high marks for quality and performance.
As the company looks toward the future, it remains dedicated to expanding its portfolio and strengthening its ties with the global scientific community, ensuring continued growth and excellence in the biotechnology field.